Cited 0 time in
Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Koo, Bon San | - |
| dc.contributor.author | Oh, Ji Seon | - |
| dc.contributor.author | Park, Seo Young | - |
| dc.contributor.author | Shin, Ji Hui | - |
| dc.contributor.author | Ahn, Ga Young | - |
| dc.contributor.author | Lee, Seunghun | - |
| dc.contributor.author | Joo, Kyung Bin | - |
| dc.contributor.author | Kim, Tae Hwan | - |
| dc.date.accessioned | 2022-07-07T13:28:07Z | - |
| dc.date.available | 2022-07-07T13:28:07Z | - |
| dc.date.issued | 2022-12 | - |
| dc.identifier.issn | 0003-4967 | - |
| dc.identifier.issn | 1468-2060 | - |
| dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/144479 | - |
| dc.format.extent | 1 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | BMJ Publishing Group | - |
| dc.title | Response to ‘Correspondence on “Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence” by Zhang et al | - |
| dc.type | Article | - |
| dc.publisher.location | 영국 | - |
| dc.identifier.doi | 10.1136/annrheumdis-2020-218944 | - |
| dc.identifier.scopusid | 2-s2.0-85141891286 | - |
| dc.identifier.wosid | 000888823300015 | - |
| dc.identifier.bibliographicCitation | Annals of the Rheumatic Diseases, v.81, no.12, pp 1 - 1 | - |
| dc.citation.title | Annals of the Rheumatic Diseases | - |
| dc.citation.volume | 81 | - |
| dc.citation.number | 12 | - |
| dc.citation.startPage | 1 | - |
| dc.citation.endPage | 1 | - |
| dc.type.docType | 정기 학술지(letter(letters to the editor)) | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Rheumatology | - |
| dc.relation.journalWebOfScienceCategory | Rheumatology | - |
| dc.subject.keywordPlus | antirheumatic agent | - |
| dc.subject.keywordPlus | tumor necrosis factor | - |
| dc.subject.keywordPlus | tumor necrosis factor inhibitor | - |
| dc.subject.keywordPlus | ankylosing spondylitis | - |
| dc.subject.keywordPlus | diagnostic imaging | - |
| dc.subject.keywordPlus | human | - |
| dc.subject.keywordPlus | pathology | - |
| dc.subject.keywordAuthor | tumor necrosis factor inhibitors | - |
| dc.subject.keywordAuthor | spondylitis | - |
| dc.subject.keywordAuthor | ankylosing | - |
| dc.subject.keywordAuthor | osteoporosis | - |
| dc.identifier.url | https://ard.bmj.com/content/early/2020/09/30/annrheumdis-2020-218944 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366
COPYRIGHT © 2024 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
